, Volume 182, Issue 4, pp 251–264

Asbestos Induces Tissue Factor in Beas-2BHuman Lung Bronchial Epithelial Cells In Vitro



Asbestos has been implicated in the pathogenesis of interstitial lung diseases including asbestosis. Tissue factor (TF) initiates blood coagulation in vivo contributing to inflammation and tissue remodeling via extravascular fibrin deposition and signaling for profibrogenic mediators. We hypothesized that asbestos could induce TF expression by lung epithelial cells. We found that TF mRNA and TF-dependent procoagulant activity were induced in asbestos-treated Beas-2B human airway epithelial cells, which we used as a model system. The effect was increased by crocidolite and chrysotile versus control particulates, including titanium dioxide (TiO2) and Wollastonite (W). Transcription factors that bind the TF gene promoter, including NF-κB, AP1 and Sp1, were induced by asbestos while TF mRNA was unstable. TF mRNA was inhibited by mithramycin in asbestos-treated as well as control cells suggesting that Sp1 contributes to TF maintenance in Beas-2B cells. Sp1 knockdown with specific siRNA decreased TF antigen, which is consistent with Sp1-mediated control of TF in Beas-2B cells. The results demonstrate that asbestos induces TF expression in lung epithelial cells in vitro, representing a newly recognized potential mechanism by which asbestos may modulate epithelial cell responses germane to lung remodeling. The mechanism involves alterations in steady-state TF mRNA that do not involve posttranscriptional regulation, implicating control of TF gene expression at the transcriptional level through Sp1 or other transcription factors.


Asbestos Tissue factor Lung epithelial cells Coagulation 


  1. 1.
    Ahern, SM, Miyata, T, Sadler, JE 1993Regulation of human tissue factor expression by mRNA turnoverJ Biol Chem26821542159PubMedGoogle Scholar
  2. 2.
    Barchowsky, A, Roussel, RR, Krieser, RJ, Mossman, BT, Treadwell, MD 1998Expression and activity of urokinase and its receptor in endothelial and pulmonary epithelial cells exposed to asbestosToxicol Appl Pharmacol152388396CrossRefPubMedGoogle Scholar
  3. 3.
    Brody, AR 1997Occupational lung diseases and the role of peptide growth factorsCurr Opin Pulm Med3203208PubMedGoogle Scholar
  4. 4.
    Brown, LF, Dvorak, AM, Dvorak, HF 1989Leaky vessels, fibrin deposition, and fibrosis: a sequence of events common to solid tumors and to many other types of diseaseAm Rev Respir Dis14011041107PubMedGoogle Scholar
  5. 5.
    Callahan, KS, Griffith, DS, Garcia, JG 1990Asbestos exposure results in increased lung procoagulant activity in vitro and in vivoChest98112119PubMedGoogle Scholar
  6. 6.
    Carson, SD, Bach, R, Carson, SM 1985Monoclonal antibodies against bovine tissue factor, which block interaction with factor VIIaBlood66152156PubMedGoogle Scholar
  7. 7.
    Cui, MZ, Parry, GC, Oeth, P,  et al. 1996Transcriptional regulation of the tissue factor gene in human epithelial cells is mediated by Sp1 and EGR-1J Biol Chem27127312739CrossRefPubMedGoogle Scholar
  8. 8.
    Fujii, M, Hayakawa, H, Urano, T,  et al. 2000Relevance of tissue factor and tissue factor pathway inhibitor for hypercoagulable state in the lungs of patients with idiopathic pulmonary fibrosisThromb Res99111117CrossRefPubMedGoogle Scholar
  9. 9.
    Gan, L, Savransky, EF, Fasy, TM, Johnson, EM 1993Transfection of human mesothehal cells mediated by different asbestos fiber typesEnviron Res622842CrossRefPubMedGoogle Scholar
  10. 10.
    Gunther, A, Mosavi, P, Ruppert, C,  et al. 2000Enhanced tissue factor pathway activity and fibrin turnover in the alveolar compartment of patients with interstitial lung diseaseThromb Haemost83853860PubMedGoogle Scholar
  11. 11.
    Howell, DC, Goldsack, NR, Marshall, RP,  et al. 2001Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosisAm J Pathol15913831395PubMedGoogle Scholar
  12. 12.
    Idell, S, Gonzalez, K, Bradford, H,  et al. 1987Procoagulant activity in bronchoalveolar lavage in the adult respiratory distress syndrome. Contribution of tissue factor associated with factor VIIAm Rev Respir Dis13614661474PubMedGoogle Scholar
  13. 13.
    Idell, S, James, KK, Levin, EG,  et al. 1989Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndromeJ. Clin Invest84695705PubMedGoogle Scholar
  14. 14.
    Idell, S, Kumar, A, Zwieb, C,  et al. 1994Effects of TGF-beta and TNF-alpha on procoagulant and fibrinolytic pathways of human tracheal epithelial cellsAm J Physiol267L693L703PubMedGoogle Scholar
  15. 15.
    Idell, S 1995

    Coagulation, fibrinolysis and fibrin deposition in lung injury and repair

    Phan, SHThrall, RS eds. Lung biology in health and disease, vol 80. Pulmonary fibrosisLenfant C Marcel DekkerNew York743776
    Google Scholar
  16. 16.
    Janssen, YM, Barchowsky, A, Treadwell, M, Driscoll, KE, Mossman, BT 1995Asbestos induces nuclear factor kappa B (NF-kappa B) DNA-binding activity and NF-kappa B-dependent gene expression in tracheal epithelial cellsProc Natl Acad Sci USA9284588462PubMedGoogle Scholar
  17. 17.
    Mackman, N 1995Regulation of the tissue factor geneFASEB J9883889PubMedGoogle Scholar
  18. 18.
    Mackman, N, Brand, K, Edgington, TS 1991Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sitesJ Exp Med17415171526CrossRefPubMedGoogle Scholar
  19. 20.
    Mossman, BT, Churg, A 1998Mechanisms in the pathogenesis of asbestosis and silicosisAm J Respir Crit Care Med15716661680PubMedGoogle Scholar
  20. 21.
    Olman, MA, Mackman, N, Gladson, CL, Moser, KM, Loskutoff, DJ 1995Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouseJ Clin Invest9616211630PubMedGoogle Scholar
  21. 22.
    Pendurthi, UR, Williams, JT, Rao, LV 1997Inhibition of tissue factor gene activation in cultured endothelial cells by curcumin. Suppression of activation of transcription factors Egr-1, AP-1, and NF-kappa BArterioscler Thromb Vasc Biol1734063413PubMedGoogle Scholar
  22. 23.
    Perkins, RC, Broaddus, VC, Shetty, S, Hamilton, S, Idell, S 1999Asbestos upregulates expression of the urokinase-type plasminogen activator receptor on mesothelial cellsAm J Respir Cell Mol Biol21637646PubMedGoogle Scholar
  23. 24.
    Petersohn, D, Thiel, G 1996Role of zinc-finger proteins Sp1 and zif268/egr-1 in transcriptional regulation of the human synaptobrevin II geneEur J Biochem239827834CrossRefPubMedGoogle Scholar
  24. 25.
    Ruf, W, Mueller, BM 1996Tissue factor in cancer angiogenesis and metastasisCurr Opin Hematol3379384PubMedGoogle Scholar
  25. 26.
    Safe, S 2001Transcriptional activation of genes by 17 beta-estradiol through estrogen receptor-Sp1 interactionsVitam Horm62231252CrossRefPubMedGoogle Scholar
  26. 27.
    Verrecchia, F, Rossert, J, Mauviel, A 2001Blocking SP1 transcription factor broadly inhibits extracellular matrix gene expression in vitro and in vivo: implications for the treatment of tissue fibrosisJ Invest Dermatol116755763CrossRefPubMedGoogle Scholar
  27. 28.
    Versteeg, HH, Peppelenbosch, MP, Spek, CA 2001The pleiotropic effects of tissue factor: a possible role for factor VIIa-induced intracellular signalling?Thromb Haemost8613531559PubMedGoogle Scholar
  28. 29.
    Welty-Wolf, KE, Carraway, MS, Idell, S,  et al. 2001Tissue factor in experimental acute lung injurySemin Hematol383538CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  1. 1.Biomedical ResearchThe University of Texas Health Center at TylerTylerUSA

Personalised recommendations